Loading...
•
Mar 30, 2024
Rayonier AM Q1 2024 Earnings Report
Rayonier AM's Q1 2024 financial performance improved, driven by lower costs and increased demand for cellulose specialties, resulting in solid Adjusted EBITDA and increased free cash flow guidance.
Key Takeaways
Rayonier Advanced Materials Inc. (RYAM) reported improved first-quarter 2024 results, exceeding expectations with a solid $52 million in Adjusted EBITDA. The company's net loss was $2 million, and net sales reached $388 million. RYAM reaffirmed its 2024 Adjusted EBITDA guidance of $180 million to $200 million and increased its Adjusted Free Cash Flow guidance to $80 million to $100 million.
Net sales for the first quarter were $388 million, a decrease of $79 million compared to the prior year quarter.
The company reported a net loss of $2 million for the first quarter, which is a $4 million decrease from the prior year quarter.
Adjusted EBITDA for the first quarter was $52 million, an increase of $1 million compared to the prior year quarter.
The company increased 2024 Adjusted Free Cash Flow guidance to a range of $80 million to $100 million.
Revenue by Segment
Forward Guidance
RYAM expects to generate between $180 million and $200 million of Adjusted EBITDA in 2024 and Adjusted Free Cash Flow between $80 million and $100 million.
Positive Outlook
- Average sales prices for cellulose specialties in 2024 are expected to increase by a low single-digit percentage as compared to average sales prices in 2023 as the Company prioritizes value over volume.
- Sales volumes for cellulose specialties are expected to be comparable to 2023 driven by increased volumes from the closure of a competitor’s plant and a modest increase in ethers sales, offset by a one-time favorable impact from a change in customer contract terms in the prior year quarter and customer destocking in the acetate markets.
- Demand for RYAM commodity products remains stable as prices are expected to be flat to 2023, despite a difficult comparison to the first quarter of 2023.
- Costs are expected to be lower in 2024 driven by lower key input and logistics costs, improved productivity and the indefinite suspension of operations at the Temiscaming High Purity Cellulose plant.
- The Company’s bioethanol facility in Tartas, France became operational in the first quarter of 2024 and is expected to deliver $3 million to $4 million of EBITDA in 2024, growing to $8 million to $10 million beginning in 2025.
Challenges Ahead
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...